Sentences with phrase «report on the current conditions»

NBC 7's Steven Luke reports on the current condition of the rescued dogs and when they could be up for adoption.

Among her recent coedited publications are Contemporary Art and Its Commercial Markets: A Report on Current Conditions and Future Scenarios, Performing the Curatorial: With and Beyond Art, and Art and the F Word: Reflections on the Browning of Europe, all of which were published by Sternberg Press.

Among her recent co-edited publications are Contemporary Art and Its Commercial Markets: A Report on Current Conditions and Future Scenarios and Performing the Curatorial: With and Beyond Art, both Sternberg Press.

Her recent co-edited publications include Contemporary Art and Its Commercial Markets: A Report on Current Conditions and Future Scenarios; Performing the Curatorial: With and Beyond Art; and Art and the F Word: Reflections on the Browning of Europe, all with Sternberg Press.

Among her recent co-edited publications are Contemporary Art and Its Commercial Markets: A Report on Current Conditions and Future Scenarios, Performing the Curatorial: With and Beyond Art, and Art and the F Word: Reflections on the Browning of Europe, all at Sternberg Press.

The New York State Department of Financial Services (DFS) asked six South Korean banks and their New York branches to report on the current conditions of digital currency transactions in South Korea and their measures to prevent money laundering.

The Inspector is trying to report on the current conditions of the home and often if they do their job well, the buyer will decide they do not want to proceed with the purchase because they are unwilling to take on the liability of the deficiencies.

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

Risk factors, cautionary statements and other conditions which could cause SkyWest's actual results to differ materially from management's current expectations are contained in SkyWest's filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10 - K and Quarterly Reports on Form 10 - Q.

Certain risk factors that may affect our business operations, financial condition and results of operations are included in our filings with the SEC, including our annual reports on Form 10 - K, quarterly reports on Form 10 - Q and current reports on Form 8 - K.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Among the likely changes to Dodd - Frank: raising the threshold for tougher oversight from the current $ 50 billion in assets to $ 250 billion; exempting small banks from the so - called Volcker rule, which currently bars them from speculative trading; reducing the amount of financial reporting, particularly racial and income data on mortgage holders; lowering the frequency of regulatory exams; and easing the conditions of stress tests.

We discuss certain of these matters more fully, as well as certain other risk factors that may affect Centene's business operations, financial condition and results of operations, in Centene's filings with the SEC, including the annual report on Form 10 - K, quarterly reports on Form 10 - Q and current reports on Form 8 - K.

Actual results may vary materially from those expressed or implied by forward - looking statements based on a number of factors, including, without limitation: (1) risks related to the consummation of the Merger, including the risks that (a) the Merger may not be consummated within the anticipated time period, or at all, (b) the parties may fail to obtain shareholder approval of the Merger Agreement, (c) the parties may fail to secure the termination or expiration of any waiting period applicable under the HSR Act, (d) other conditions to the consummation of the Merger under the Merger Agreement may not be satisfied, (e) all or part of Arby's financing may not become available, and (f) the significant limitations on remedies contained in the Merger Agreement may limit or entirely prevent BWW from specifically enforcing Arby's obligations under the Merger Agreement or recovering damages for any breach by Arby's; (2) the effects that any termination of the Merger Agreement may have on BWW or its business, including the risks that (a) BWW's stock price may decline significantly if the Merger is not completed, (b) the Merger Agreement may be terminated in circumstances requiring BWW to pay Arby's a termination fee of $ 74 million, or (c) the circumstances of the termination, including the possible imposition of a 12 - month tail period during which the termination fee could be payable upon certain subsequent transactions, may have a chilling effect on alternatives to the Merger; (3) the effects that the announcement or pendency of the Merger may have on BWW and its business, including the risks that as a result (a) BWW's business, operating results or stock price may suffer, (b) BWW's current plans and operations may be disrupted, (c) BWW's ability to retain or recruit key employees may be adversely affected, (d) BWW's business relationships (including, customers, franchisees and suppliers) may be adversely affected, or (e) BWW's management's or employees» attention may be diverted from other important matters; (4) the effect of limitations that the Merger Agreement places on BWW's ability to operate its business, return capital to shareholders or engage in alternative transactions; (5) the nature, cost and outcome of pending and future litigation and other legal proceedings, including any such proceedings related to the Merger and instituted against BWW and others; (6) the risk that the Merger and related transactions may involve unexpected costs, liabilities or delays; (7) other economic, business, competitive, legal, regulatory, and / or tax factors; and (8) other factors described under the heading «Risk Factors» in Part I, Item 1A of BWW's Annual Report on Form 10 - K for the fiscal year ended December 25, 2016, as updated or supplemented by subsequent reports that BWW has filed or files with the SEC.

The Beige Book is a commonly used name for the Fed report called the Summary of Commentary on Current Economic Conditions by Federal Reserve District.

Focusing on the United Kingdom, we believe current conditions favor large UK multinational companies that obtain much of their earnings abroad or report their results in foreign currencies (e.g., global integrated oil and gas companies).

A number of factors could cause actual results or outcomes to differ materially from those indicated by such forward - looking statements, including but not limited to, (1) our ability to open new restaurants and food and beverage locations in current and additional markets, grow and manage growth profitably, maintain relationships with suppliers and obtain adequate supply of products and retain our key employees; (2) factors beyond our control that affect the number and timing of new restaurant openings, including weather conditions and factors under the control of landlords, contractors and regulatory and / or licensing authorities; (3) changes in applicable laws or regulations; (4) the possibility that the Company may be adversely affected by other economic, business, and / or competitive factors; and (5) other risks and uncertainties indicated from time to time in our filings with the SEC, including our Annual Report on Form 10 - K filed on March 30, 2016 and our Quarterly Report on Form 10 - Q filed on August 15, 2016.

A fellow of the National Athletic Trainers» Association and the American College of Sports Medicine, Dr. Casa has been a lead or co-author on numerous sports medicine (ACSM, NATA) position statements related to heat illness and hydration, is an associate editor of the Journal of Athletic Training, on the editorial board of Current Sports Medicine Reports, Journal of Sport Rehabilitation, and the Journal of Strength and Conditioning Research and a frequent contributor to numerous media outlets, including theToday Show, and Good Morning America, ESPN, CNN, PBS, and publications such as Sports Illustrated, USA Today, The Wall Street Journal and The New York Times.

This past June scientists at NASA's Stennis Space Center in Mississippi reported that the eyewall's extreme conditions can stir up ocean currents 300 feet below the surface, disrupting sediment and organisms on the seafloor for as long as a week after the storm subsides.

Balazs and his colleagues report in the current issue of the Marine Pollution Bulletin how 300 pellets a day were washing up on Kualoa Beach: «A general review of data for tidal cycles, moon phases, wind speed and direction, and surf conditions failed to identify any consistent correlation with the erratic fluctuations in daily faecal counts.»

Ocean conditions off most of the U.S. West Coast are returning roughly to average, after an extreme marine heat wave from about 2014 to 2016 disrupted the California Current Ecosystem and shifted many species beyond their traditional range, according to a new report from NOAA Fisheries» two marine laboratories on the West Coast.

You will have to teach them how to do almost everything because they've been so conditioned to read a question and find the answer staring back at them in bold print on the page of a textbook - to search for answers in current events reports is much harder.

The inspection report will detail the current condition of a home and list any problems that may be on the horizon.

maintain books on a double - entry system and keep complete records in accordance with generally accepted accounting principles and report to the Board at every meeting the condition of the Club's finances based on the latest financial statement and current information; (4.)

prepare complete three months, six months, nine months and twelve months (annual) financial statements in accordance with generally accepted accounting principles and report to the Board at every meeting the condition of the Club's finances based on the latest financial statement and current information; (5.)

In response, the Akademie der Künste is presenting a new event series «You Want Kilims, But I Do Films», (quoting Kurdish born film director Atif Yilmaz) which artists, writers, journalists and scholars will provide insight into their current practice and report on the working conditions prevailing in Turkey.

The SIO produces reports in June, July, and August containing a variety of perspectives on Arctic sea ice — from observations of current conditions, to advanced numerical models, to qualitative perspectives from citizen scientists.

The report includes comments on modeling outlooks and on regional predictions, a summary of current conditions, key statements from each Outlook, and links to view or download the full outlook contributions.

This month's full report includes the comments on modeling outlook, a summary of current conditions, key statements from each Outlook, and links to view or download the full outlook contributions.

The Sea Ice Outlook, an activity of the Sea Ice Prediction Network and a contribution to SEARCH, produces reports in June, July, and August containing a variety of perspectives on Arctic sea ice — from observations of current conditions, to advanced numerical models, to qualitative perspectives from citizen scientists.

Performed testing activities for Patient Care Management tool, which enables medical staffs to Check - in patients, Create and manage patient profile including their current medical condition, document outcome of evaluation / diagnosis including short - term and long - term care needs and treatment plans, assign patient to medical staff based on treatment plan, document treatment progress, submit claims for insurance purpose and generate various types of reporting for management

Commenting on the current Royal Commission into the Protection and Detention of Children in the Northern Territory, Mr Kirby said media reports of the conditions in some communities was «a horrible thought for us Australians to think about and to reflect upon».

The Michigan sentiment report showed that a gauge of U.S. consumers» views on current conditions rose to 85.7 in December from 82.1 in November, while a reading on their expectations increased to 66.8 from 64.8.

Nanny reports that current market conditions vary depending on price range.

«This condition occurred because the sources used by lenders to identify ineligible borrowers lacked sufficient current information, and FHA did not adequately guide lenders on reviewing child support,» the report notes.

According to the University of Michigan report, a gauge of consumers» views on current economic conditions rose to 98 in May from 89.9 in April.

In addition, actual results are subject to other risks and uncertainties that relate more broadly to News Corp's overall business, including those more fully described in News Corp's filings with the U.S. Securities and Exchange Commission («SEC») including its annual report on Form 10 - K for the fiscal year ended June 30, 2014, and its quarterly reports filed on Form 10 - Q for the current fiscal year, and Move's overall business and financial condition, including those more fully described in Move's filings with the SEC including its annual report on Form 10 - K for the fiscal year ended December 31, 2013, and its quarterly reports filed on Form 10 - Q for the current fiscal year.

In this week's economic review, nonfarm payrolls grew more than expected and consumers are reporting high optimism in current economic conditions while spending more on revolving credit.

The inspection report will detail the current condition of a home and list any problems that may be on the horizon.